The effect of prior transarterial chemoembolization on response to immune checkpoint inhibitor treatment in patients with hepatocellular carcinoma - PubMed
6 hours ago
- #Immune Checkpoint Inhibitor
- #Hepatocellular Carcinoma
- #Transarterial Chemoembolization
- The study examines how prior transarterial chemoembolization (TACE) affects response to immune checkpoint inhibitor (ICI) treatment in hepatocellular carcinoma (HCC) patients.
- Key drugs involved include durvalumab and tremelimumab, which are part of the ICI therapy regimen.
- The research aims to determine the impact of TACE on the efficacy of subsequent immune checkpoint inhibitor treatments in HCC.